Endostatin Interventional Effect on Colorectal Cancer Liver Metastasis

骆成玉,赵丹宁,李世拥,杨晓明,梁龙,祝学光
DOI: https://doi.org/10.3760/j:issn:0529-5815.2001.03.006
2001-01-01
Abstract:Objective To study the influence of angiogenesis inhibitor-endostatin on colorectal cancer liver metastasis. Methods Thirty-two nude mice model of colorectal cancer liver metastasis was established by splenectomy. Mice were randomly divided into 4 groups: control group given saline solution, treatment group Ⅰ 5-Fu, treatment group Ⅱ endostatin, and treatment group Ⅲ both 5-Fu and endostatin. The differences of liver metastasis between the groups were compared. Results The incidences of liver metastasis and mean numbers of liver tumors decreased substantially in the mice treated with endostatin and combined drugs. The survival times of animals were significantly longer in the endostatin group and the 5-Fu and endostatin group than in the 5-Fu group and control group. The inhibition effect of liver metastasis by 5-Fu was relatively weaker. Conclusions Endostatin greatly affects the development of colorectal cancer liver metastasis. It is more effective than 5-Fu in clinical application.
What problem does this paper attempt to address?